Bernard Fox, Co-Founder, President and CEO of UbiVac, posted on X:
“TIMO2025 Great line-up of immunotherapy experts/I talked Cancer antigens and Dark Genome-derived, Dark Matter/ IMO: Recent studies explain why combination #immunotherapy with personalized neoantigen vaccines SUBOPTIMAL.”
More posts featuring Bernard Fox.